In March 2026, Indivior Pharmaceuticals, Inc. completed an upsized private offering of US$450,000,000 in 0.625% convertible senior unsecured notes due March 15, 2031, using the proceeds to repay ...
A lifetime license for Mac or PC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results